当前位置: 首页 > 期刊 > 《中国中药杂志》 > 2012年第20期
编号:13176557
桥本甲状腺炎病因病机与临床治疗研究进展(5)
http://www.100md.com 2012年10月15日 《中国中药杂志》 2012年第20期
     GAO Qing1, JIAN Li-xin2, XU Jin-guo1, LI Wen-lin1, JIAN Zhi-wei2, PAN Su-hua1*

    (1.Nanjing University of Traditional Chinese Medicine, Zhuhai 519000, China; 2. Nu Life International(Asia)Ltd., Zhuhai 519000, China)

    [Abstract]Hashimoto′s thyroiditis (HT) is a autoimmune disease that is highly incident year by year. Its clinical manifestations are alternative hyperthyroidism or hypothyroidism, relatively high Th1, excessively low Th2 and constantly increasing TGAb and TMAB. Currently, the disease is still difficult to be cured, and instable thyroid function makes it harder to be treated. Therefore, this essay makes a summary analysis on domestic and foreign studies on HT′s pathogenesis, clinical manifestations and treatment, resulting that pure supplement or immunosuppressive therapy is hard to achieve notable efficacy, while existing traditional Chinese medicines could only mitigate clinical symposiums but did not reduce inflammation. Therefore, to look for methods and drugs for adjusting immunity imbalance by decreasing Th1 cell factors and increasing Th2 cell factors is significant to HT treatment to some extent.

    [Key words]Hashimoto′s thyroiditis; syndrome differentiations; immune adjustment

    doi:10.4268/cjcmm20122001

    [责任编辑陈玲], 百拇医药(高青 简立信 许金国 李文林 简志伟 潘苏华)
上一页1 2 3 4 5